Evolv Technologies Holdings, Inc. (EVLV) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EVLV SEC filings page.
Evolv Technologies Holdings, Inc. (EVLV) reported $171.4M in revenue over the twelve months to Jun 30, 2026, up 41.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue is scaling while margins improve, but the business still relies on financing as investment outflows exceed internally generated cash.
The key shift is in cash conversion: FY2025 produced operating cash flow of$18.7M despite a net loss of$33.1M , suggesting noncash charges and working-capital movements materially softened the accounting loss. Yet investing cash flow was-$41.8M , so positive operations did not fund the year's investment without external financing.
Gross margin expanded from
The current ratio fell from 2.1x in FY2023 to 1.2x in FY2025, leaving less short-term cushion as sales expanded. Debt-to-equity reached 0.2x from 0.0x over the same span, showing a shift from an almost debt-free posture even as operating cash turned positive.
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Evolv Technologies Holdings, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Evolv Technologies Holdings, Inc. held $69.0M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $18.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Evolv Technologies Holdings, Inc. scores 86/100 among other emerging companies.
Evolv Technologies Holdings, Inc. had 179M shares outstanding at the end of fiscal year 2025, against 163M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Evolv Technologies Holdings, Inc. scores 51/100 among other emerging companies.
Evolv Technologies Holdings, Inc. spent $20.6M on research and development in fiscal year 2025, which was 10.6% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Evolv Technologies Holdings, Inc. scores 37/100 among other emerging companies.
Evolv Technologies Holdings, Inc. reported revenue of $145.9M in fiscal year 2025, against $103.9M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Evolv Technologies Holdings, Inc. scores 74/100 among other emerging companies.
Evolv Technologies Holdings, Inc.'s operations generated $18.7M of cash in fiscal year 2025, against $30.9M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Evolv Technologies Holdings, Inc. scores 97/100 among other emerging companies.
Evolv Technologies Holdings, Inc.'s cash, cash equivalents and investments came to $69.0M at the end of fiscal year 2025, against $185.0M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Evolv Technologies Holdings, Inc. scores 37/100 among other emerging companies.
Evolv Technologies Holdings, Inc. scores 0.97, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($827.7M) relative to total liabilities ($185.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Evolv Technologies Holdings, Inc. passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
Evolv Technologies Holdings, Inc. reported a net loss of $33.1M while generating $18.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Evolv Technologies Holdings, Inc. reported an operating loss of $48.5M against $1.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Evolv Technologies Holdings, Inc. generated $43.8M in revenue in Q2 2026. This represents an increase of 34.4% from the same quarter a year earlier. Against the prior quarter it is down 5.6%.
Evolv Technologies Holdings, Inc.'s EBITDA was -$3.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 70.5% from the same quarter a year earlier. Against the prior quarter it is down 106.5%.
Evolv Technologies Holdings, Inc. reported -$9.3M in net income in Q2 2026. This represents an increase of 77.1% from the same quarter a year earlier. Against the prior quarter it is down 85.6%.
Evolv Technologies Holdings, Inc. earned -$0.05 per diluted share (EPS) in Q2 2026. This represents an increase of 80.0% from the same quarter a year earlier. Against the prior quarter it is down 66.7%.
Cash & Balance Sheet
Evolv Technologies Holdings, Inc. held $52.7M in cash against $28.7M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Evolv Technologies Holdings, Inc.'s gross margin was 50.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
Evolv Technologies Holdings, Inc.'s operating margin was -24.1% in Q2 2026, reflecting core business profitability. This is up 29.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 5.8 percentage points.
Evolv Technologies Holdings, Inc.'s net profit margin was -21.3% in Q2 2026, showing the share of revenue converted to profit. Against the prior quarter it is down 10.4 percentage points. No change is given against Q2 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Evolv Technologies Holdings, Inc.'s ROE was -7.8% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 35.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.7 percentage points.
Capital Allocation
Evolv Technologies Holdings, Inc. invested $5.8M in research and development in Q2 2026. This represents an increase of 22.0% from the same quarter a year earlier. Against the prior quarter it is down 1.8%.
Not reported for Q2 2026.
Not reported for Q2 2026.
EVLV Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $43.8M+34.4% | $46.3M+44.7% | $38.5M+32.3% | $42.9M+56.6% | $32.5M+29.0% | $32.0M+44.3% | $29.1M+41.4% | $27.4M+37.1% |
| Cost of Revenue | $21.8M+33.5% | $22.7M+76.8% | $19.9M+60.8% | $21.5M+86.5% | $16.3M+56.0% | $12.9M+28.2% | $12.4M+12.2% | $11.6M+27.4% |
| Gross Profit | $22.0M+35.4% | $23.6M+23.2% | $18.6M+11.3% | $21.3M+34.8% | $16.2M+9.9% | $19.1M+57.5% | $16.7M+75.1% | $15.8M+45.2% |
| R&D Expenses | $5.8M+22.0% | $5.9M+21.0% | $5.4M+0.4% | $5.6M-3.5% | $4.7M-19.0% | $4.9M-24.0% | $5.4M-14.5% | $5.8M-9.0% |
| SG&A Expenses | $14.0M-18.6% | $13.5M-9.7% | $10.1M-39.9% | $12.6M-10.0% | $17.2M+22.6% | $15.0M+26.8% | $16.8M+50.6% | $14.0M+24.1% |
| Operating Income | -$10.6M+39.7% | -$8.5M+41.1% | -$8.0M+57.7% | -$8.6M+55.1% | -$17.5M+21.8% | -$14.4M+34.3% | -$18.9M+15.0% | -$19.2M+9.6% |
| EBITDA | -$3.5M+70.5% | -$1.7M+81.1% | -$1.5M+89.0% | -$2.1M+85.6% | -$11.7M+36.7% | -$8.9M+52.0% | -$13.4M+29.6% | -$14.6M+21.7% |
| Interest Expense | $965K | $962K+96100.0% | $1.0M | $713K | $0 | $1K | N/A | $0 |
| Income Tax | $0+100.0% | -$37K-158.7% | $0 | $0 | -$1K | $63K | N/A | $0 |
| Net Income | -$9.3M+77.1% | -$5.0M-196.6% | $10.9M+169.2% | -$1.8M+94.1% | -$40.5M-1285.9% | -$1.7M+85.0% | -$15.7M+8.6% | -$30.4M-703.3% |
| EPS (Basic) | -$0.05+80.0% | -$0.03-200.0% | $0.06+166.7% | -$0.01+94.7% | -$0.25-1350.0% | -$0.01+85.7% | -$0.09+18.2% | -$0.19-733.3% |
| EPS (Diluted) | -$0.05+80.0% | -$0.03-200.0% | $0.06+166.7% | -$0.01+94.7% | -$0.25-1350.0% | -$0.01+85.7% | -$0.09+18.2% | -$0.19-733.3% |
| Diluted Shares (Avg) | 180M+9.0% | 177M+10.1% | N/A | 173M+9.6% | 165M-3.7% | 161M+5.1% | N/A | 158M-9.4% |
EVLV Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $302.0M+7.7% | $304.6M+19.0% | $304.4M+13.6% | $304.3M+9.3% | $280.4M+4.2% | $256.0M-8.6% | $268.1M-9.8% | $278.5M-8.5% |
| Current Assets | $149.4M+12.3% | $152.0M+46.5% | $151.3M+24.6% | $151.6M+12.8% | $133.1M-3.1% | $103.8M-24.9% | $121.4M-29.9% | $134.4M-32.5% |
| Cash & Equivalents | $52.7M+42.6% | $56.1M+123.5% | $49.1M+32.8% | $31.5M-31.6% | $36.9M+3.5% | $25.1M-43.7% | $37.0M-44.9% | $46.0M-53.8% |
| Short-Term Investments | $9.9M | $5.0M-49.7% | $19.9M+33.2% | $24.7M+148.2% | $0-100.0% | $9.9M-72.7% | $14.9M-70.9% | $10.0M-74.8% |
| Inventory | $8.7M-28.7% | $8.3M-17.9% | $9.3M-45.1% | $8.8M-46.1% | $12.1M-36.5% | $10.1M-12.7% | $17.0M+64.0% | $16.3M+100.0% |
| Accounts Receivable | $39.6M-5.3% | $42.7M+23.9% | $30.8M+8.6% | $48.9M+40.2% | $41.8M+18.0% | $34.5M+75.4% | $28.4M+31.8% | $34.9M+27.5% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $183.2M-2.5% | $184.0M+36.4% | $185.0M+23.0% | $202.1M+35.2% | $187.8M+59.3% | $134.9M-3.8% | $150.4M-1.7% | $149.5M-0.1% |
| Current Liabilities | $126.8M-11.2% | $125.9M+33.3% | $123.0M+27.2% | $119.3M+33.4% | $142.9M+78.4% | $94.4M+23.6% | $96.7M+19.0% | $89.5M+20.2% |
| Non-Current Liabilities | $56.3M+25.5% | $58.1M+43.4% | $62.0M+15.5% | $82.7M+37.8% | $44.9M+18.9% | $40.5M-36.5% | $53.7M-25.1% | $60.0M-20.3% |
| Long-Term Debt | $28.7M | $28.7M | $28.6M | $28.5M | N/A | N/A | $0 | N/A |
| Total Equity | $118.9M+28.3% | $120.7M-0.3% | $119.4M+1.5% | $102.2M-20.7% | $92.7M-38.7% | $121.1M-13.4% | $117.7M-18.4% | $129.0M-16.6% |
| Retained Earnings | -$402.1M-1.3% | -$392.8M-10.2% | -$387.8M-9.3% | -$398.7M-17.6% | -$396.9M-28.7% | -$356.4M-14.2% | -$354.7M-18.0% | -$338.9M-19.6% |
Not reported in any period shown, so not listed: Goodwill.
EVLV Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $11.9M+463.3% | -$3.2M-25.2% | $15.6M+386.0% | $3.5M-4.1% | $2.1M+109.8% | -$2.5M+84.3% | $3.2M+201.9% | $3.7M+75.3% |
| Depreciation & Amortization | $7.1M+22.4% | $6.8M+23.0% | $6.5M+19.1% | $6.5M+41.3% | $5.8M+48.7% | $5.5M+60.0% | $5.4M+73.8% | $4.6M+76.9% |
| Stock-Based Compensation | $6.9M+23.5% | $5.6M+14.5% | N/A | $5.4M-28.2% | $5.5M-25.3% | $4.9M-24.1% | N/A | $7.5M+24.4% |
| Investing Cash Flow | -$14.8M-357.4% | $9.8M+204.3% | $1.4M+110.6% | -$39.6M-735.8% | $5.8M-53.4% | -$9.4M-39.3% | -$13.3M+56.3% | $6.2M+121.7% |
| Financing Cash Flow | $245K-94.0% | $322K+1510.0% | $679K+3.2% | $30.6M+5847.0% | $4.1M+1120.1% | $20K-93.4% | $658K+1165.4% | $515K+89.3% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
EVLV Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 50.2%+0.3pp | 50.9%-8.9pp | 48.4%-9.2pp | 49.7%-8.1pp | 49.8%-8.7pp | 59.8%+5.0pp | 57.5%+11.1pp | 57.8%+3.2pp |
| Operating Margin | -24.1%+29.6pp | -18.3%+26.7pp | -20.7%+44.1pp | -20.1%+49.9pp | -53.8%+34.9pp | -45.0%+53.8pp | -64.9% | -70.0% |
| Net Margin | -21.3% | -10.8%-5.5pp | 28.3%+82.3pp | -4.2% | -124.6% | -5.3%+45.5pp | -54.0%+29.5pp | -111.3% |
| Return on Equity | -7.8%+35.9pp | -4.2%-2.8pp | 9.1%+22.5pp | -1.8%+21.8pp | -43.8%-46.0pp | -1.4%+6.7pp | -13.4%-1.4pp | -23.6%-26.9pp |
| Return on Assets | -3.1%+11.4pp | -1.6%-1.0pp | 3.6%+9.4pp | -0.6%+10.3pp | -14.4%-15.7pp | -0.7%+3.4pp | -5.9%-0.1pp | -10.9%-12.6pp |
| Current Ratio | 1.18+0.2x | 1.21+0.1x | 1.230.0x | 1.27-0.2x | 0.93-0.8x | 1.10-0.7x | 1.26-0.9x | 1.50-1.2x |
| Debt-to-Equity | 0.24-1.8x | 0.24-0.9x | 0.24+0.2x | 0.28-0.9x | 2.03+1.2x | 1.11+0.1x | 0.000.0x | 1.16+1.2x |
| Asset Turnover | 0.140.0x | 0.150.0x | 0.130.0x | 0.140.0x | 0.120.0x | 0.130.0x | 0.110.0x | 0.100.0x |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Evolv Technologies Holdings, Inc. EVLV | FY2025 | $145.9M | -$33.1M | -22.7% | $827.7M | 64/100 |
| Napco Security Technologies, Inc NSSC | FY2026 | $202.3M | $43.0M | 21.3% | $1.3B | 79/100 |
| Mistras Group Inc. MG | FY2025 | $724.0M | $16.8M | 2.3% | $657.9M | 42/100 |
| CoreCivic, Inc. CXW | FY2025 | $2.2B | $116.5M | 5.3% | $3.3B | 35/100 |
| NLI Holdings, Inc. NL | FY2025 | $158.3M | -$37.8M | -23.9% | $341.3M | 54/100 |
| Brady Corporation BRC | FY2026 | $1.7B | $205.4M | 12.4% | $4.0B | 77/100 |
Where Evolv Technologies Holdings, Inc. Ranks
Frequently Asked Questions
What is Evolv Technologies Holdings, Inc.'s annual revenue?
Evolv Technologies Holdings, Inc. (EVLV) reported $145.9M in total revenue for fiscal year 2025. This represents a 40.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Evolv Technologies Holdings, Inc.'s revenue growing?
Evolv Technologies Holdings, Inc. (EVLV) revenue grew by 40.5% year-over-year, from $103.9M to $145.9M in fiscal year 2025.
Is Evolv Technologies Holdings, Inc. profitable?
No, Evolv Technologies Holdings, Inc. (EVLV) reported a net income of -$33.1M in fiscal year 2025, with a net profit margin of -22.7%.
What is Evolv Technologies Holdings, Inc.'s EBITDA?
Evolv Technologies Holdings, Inc. (EVLV) had EBITDA of -$24.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Evolv Technologies Holdings, Inc. have?
As of fiscal year 2025, Evolv Technologies Holdings, Inc. (EVLV) had $49.1M in cash and equivalents against $28.6M in long-term debt.
What is Evolv Technologies Holdings, Inc.'s gross margin?
Evolv Technologies Holdings, Inc. (EVLV) had a gross margin of 51.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Evolv Technologies Holdings, Inc.'s operating margin?
Evolv Technologies Holdings, Inc. (EVLV) had an operating margin of -33.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Evolv Technologies Holdings, Inc.'s net profit margin?
Evolv Technologies Holdings, Inc. (EVLV) had a net profit margin of -22.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Evolv Technologies Holdings, Inc.'s return on equity (ROE)?
Evolv Technologies Holdings, Inc. (EVLV) has a return on equity of -27.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Evolv Technologies Holdings, Inc.'s operating cash flow?
Evolv Technologies Holdings, Inc. (EVLV) generated $18.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Evolv Technologies Holdings, Inc.'s total assets?
Evolv Technologies Holdings, Inc. (EVLV) had $304.4M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Evolv Technologies Holdings, Inc. spend on research and development?
Evolv Technologies Holdings, Inc. (EVLV) invested $20.6M in research and development during fiscal year 2025.
What is Evolv Technologies Holdings, Inc.'s current ratio?
Evolv Technologies Holdings, Inc. (EVLV) had a current ratio of 1.23 as of fiscal year 2025, which is considered adequate.
What is Evolv Technologies Holdings, Inc.'s debt-to-equity ratio?
Evolv Technologies Holdings, Inc. (EVLV) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Evolv Technologies Holdings, Inc.'s return on assets (ROA)?
Evolv Technologies Holdings, Inc. (EVLV) had a return on assets of -10.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Evolv Technologies Holdings, Inc.'s P/E ratio?
Evolv Technologies Holdings, Inc. (EVLV) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $827.7M as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Evolv Technologies Holdings, Inc.'s price-to-sales ratio?
Evolv Technologies Holdings, Inc. (EVLV) trades at 4.8x sales, its market capitalization divided by revenue of $171.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $827.7M as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Evolv Technologies Holdings, Inc.'s Altman Z-Score?
Evolv Technologies Holdings, Inc. (EVLV) has an Altman Z-Score of 0.97, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Evolv Technologies Holdings, Inc.'s Piotroski F-Score?
Evolv Technologies Holdings, Inc. (EVLV) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Evolv Technologies Holdings, Inc.'s earnings high quality?
Evolv Technologies Holdings, Inc. (EVLV) reported a net loss of $33.1M while generating $18.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Evolv Technologies Holdings, Inc. cover its interest payments?
Evolv Technologies Holdings, Inc. (EVLV) reported an operating loss of $48.5M against $1.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Evolv Technologies Holdings, Inc.?
Evolv Technologies Holdings, Inc. (EVLV) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.